Drug Type Monoclonal antibody |
Synonyms BL-9020, EDP-10, JHL-1311 + [1] |
Target |
Mechanism NKp46 inhibitors(Natural cytotoxicity triggering receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Preclinical | - | 08 Jan 2014 | |
Diabetes Mellitus, Type 1 | Preclinical | - | 08 Jan 2014 |